Literature DB >> 34051403

Compassionate use of cefiderocol for VIM metallo-β-lactamase-producing Pseudomonas aeruginosa infection in a toddler with Burkitt lymphoma.

Carlos D Grasa1, María Rosa Gómez-Gil2, Sonsoles San Román Pacheco3, Teresa Del Rosal4, Francisco Moreno5, Nathalia Gerig4, Bárbara Ochoa Fernández3, Cristina Calvo4, Fernando Baquero-Artigao4.   

Abstract

Entities:  

Year:  2021        PMID： 34051403     DOI： 10.1016/j.jgar.2021.04.025

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN： 2213-7165            Impact factor:   4.035


× No keyword cloud information.
  1 in total

Review 1.  Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence.

Authors:  Chuanhai Wang; Deqing Yang; Yifan Wang; Wentao Ni
Journal:  Front Pharmacol       Date:  2022-04-12       Impact factor: 5.988
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.